Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate COVID-19 Clinical Trial
Company to test LAU-7b’s dual pro-resolving inflammation and antiviral properties against COVID-19
Committed to developing treatments
for orphan diseases
Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.
 |
 |
 |
Cystic Fibrosis |
Science |
LAU-7B |
Events
Laurent Pharmaceuticals to participate at NACFC 2019, in Nashville TN, October 31st - November 2nd 2019
Laurent Pharmaceuticals to participate at BIO2019, in Philadelphia PA, June 3-6 2019